Although various businesses have distinct purchasing procedures, payment options like T/T, the LC, and DA can accommodate them
PMC 4912689
In SURMOUNT 1, tirzepatide induced a mean BW reduction of 15.0%, 19.5% and 20.9% with 5 mg, 10 mg and 15 mg, respectively compared to 3.1% obtained with placebo at 72 weeks 34
May your washout stay clean, your titration stay smooth, and your results stay exceptional.
Who its for May be a fit if you Would rather avoid needles Are exploring provider-guided weight management Are navigating weight changes in perimenopause or menopause Want licensed provider oversight and ongoing support Not appropriate if you Have a personal or family history of medullary thyroid carcinoma or MEN 2 Are pregnant, trying to conceive, or breastfeeding Have a history of pancreatitis or certain GI conditions (discuss with your provider) Are advised against GLP-1 care by your provider Eligibility is always determined by a licensed provider after reviewing your intake
Contact your GP or healthcare provider for assessment to exclude other causes such as inflammatory arthritis or injury